Celcuity posts better-than-expected Q4 adjusted net loss
Brief: Celcuity Inc. Reports Release Of Fourth Quarter And Full Year 2025 Financial Results And Provides Corporate Update
Brief: Celcuity Q4 Adjusted EPS USD -0.73 Vs. IBES Estimate USD -1.04
U.S. RESEARCH ROUNDUP-KKR, Sirius XM, Workday
Brief: Celcuity Files For Mixed Shelf Size Not Disclosed - SEC Filing
U.S. RESEARCH ROUNDUP-Green Brick Partners, Pultegroup, Toll Brothers
Celcuity dips as H.C. Wainwright downgrades to 'neutral'
U.S. RESEARCH ROUNDUP-Abbvie, BristolMyers Squibb, Diversified Healthcare
Cancer diagnostics firm Celcuity posts smaller-than-expected Q3 adjusted loss per share
Brief: Celcuity Q3 Adjusted EPS USD -0.78 Vs. IBES Estimate USD -1.02
Brief: Celcuity Announces Upsized Senior Secured Term Loan Facility Of $500 Million With Innovatus Capital Partners And Oxford Finance
Brief: Celcuity To Initiate NDA Submission Of Gedatolisib In PIK3CA Wild-Type Cohort In HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program
U.S. RESEARCH ROUNDUP-Applied Materials, Precigen, Transdigm Group
Celcuity Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Celcuity Q2 Adjusted EPS USD -0.93 Vs. IBES Estimate USD -0.88
Celcuity Inc expected to post a loss of 88 cents a share - Earnings Preview
Celcuity Inc expected to post a loss of 88 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Altria, Meta, FuboTV
U.S. STOCKS ON THE MOVE-Electronic Arts, AEP, Peloton Interactive